BE850492A - Nouveaux derives de la piperazine - Google Patents

Nouveaux derives de la piperazine

Info

Publication number
BE850492A
BE850492A BE174169A BE174169A BE850492A BE 850492 A BE850492 A BE 850492A BE 174169 A BE174169 A BE 174169A BE 174169 A BE174169 A BE 174169A BE 850492 A BE850492 A BE 850492A
Authority
BE
Belgium
Prior art keywords
piperazine
new derivatives
derivatives
new
Prior art date
Application number
BE174169A
Other languages
English (en)
French (fr)
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of BE850492A publication Critical patent/BE850492A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BE174169A 1976-02-07 1977-01-18 Nouveaux derives de la piperazine BE850492A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
BE850492A true BE850492A (fr) 1977-07-18

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
BE174169A BE850492A (fr) 1976-02-07 1977-01-18 Nouveaux derives de la piperazine

Country Status (25)

Country Link
US (1) US4079137A (de)
JP (1) JPS52105186A (de)
AT (1) AT355578B (de)
AU (1) AU504526B2 (de)
BE (1) BE850492A (de)
CA (1) CA1094560A (de)
CH (1) CH631448A5 (de)
CS (1) CS201544B2 (de)
DD (1) DD128133A5 (de)
DE (1) DE2604845A1 (de)
DK (1) DK138891C (de)
ES (1) ES455691A1 (de)
FI (1) FI63226C (de)
FR (1) FR2340311A1 (de)
GB (1) GB1550545A (de)
HU (1) HU173483B (de)
IE (1) IE44339B1 (de)
IL (1) IL51316A (de)
LU (1) LU76706A1 (de)
NL (1) NL7700841A (de)
NO (1) NO142625C (de)
PL (1) PL105526B1 (de)
PT (1) PT66154B (de)
SE (1) SE7701187L (de)
ZA (1) ZA77248B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
CA2588685A1 (en) * 2004-12-06 2006-06-15 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
WO2009075813A1 (en) * 2007-12-12 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
EP2240194A4 (de) * 2007-12-13 2011-12-21 Sciclone Pharmaceuticals Inc Melanombehandlung mit alpha-thymosin-peptiden in kombination mit einem kinase-inhibitor
WO2009079338A1 (en) * 2007-12-14 2009-06-25 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
TWI749433B (zh) 2014-10-21 2021-12-11 開曼群島商賽生製藥國際有限公司 用免疫刺激物治療癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
FR2340311A1 (fr) 1977-09-02
CH631448A5 (de) 1982-08-13
HU173483B (hu) 1979-05-28
CS201544B2 (en) 1980-11-28
IE44339B1 (en) 1981-10-21
NO770374L (no) 1977-08-09
IL51316A0 (en) 1977-03-31
ZA77248B (en) 1977-11-30
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
FR2340311B1 (de) 1980-02-08
LU76706A1 (de) 1977-06-28
NL7700841A (nl) 1977-08-09
JPS52105186A (en) 1977-09-03
AU2195277A (en) 1978-08-10
SE7701187L (sv) 1977-08-08
AU504526B2 (en) 1979-10-18
GB1550545A (en) 1979-08-15
DK138891B (da) 1978-11-13
FI770398A (de) 1977-08-08
PT66154B (fr) 1978-07-07
FI63226C (fi) 1983-05-10
NO142625C (no) 1980-09-17
DK49077A (da) 1977-08-08
DD128133A5 (de) 1977-11-02
PT66154A (fr) 1977-03-01
DE2604845A1 (de) 1977-08-18
IE44339L (en) 1977-08-07
AT355578B (de) 1980-03-10
DK138891C (da) 1979-04-23
PL105526B1 (pl) 1979-10-31
IL51316A (en) 1980-12-31
CA1094560A (en) 1981-01-27
NO142625B (no) 1980-06-09
ATA68177A (de) 1979-08-15
ES455691A1 (es) 1978-01-01

Similar Documents

Publication Publication Date Title
BE859912A (fr) Nouveaux derives de psoralene
BE852060A (fr) Derives polyoxygenes du labdane
BE868532A (fr) Nouveaux derives de la thiazolidine
BE863314A (fr) Derives enti-paludeens de la pyrimidine
BE852141A (fr) Nouveaux derives de sulfonamide
FR2298332A1 (fr) Nouveaux derives de 5-fluorouraciles
FR2316926A1 (fr) Nouveaux derives de bicycloheptenes
BE850492A (fr) Nouveaux derives de la piperazine
FR2301253A1 (fr) Derives de la
BE850628A (fr) Nouveaux derives de la piperazine et de ses homologues
BE851443A (fr) Nouveaux derives de la piperazine
BE853578A (fr) Derives de thiouree
BE859439A (fr) Nouveaux derives de piperazine
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
FR2306694A1 (fr) Derives de la piperazine
BE859567A (fr) Derives piperidylideniques de benzo-xanthenes
BE854249A (fr) Nouveaux derives des benzodiazepines
BE850528A (fr) Nouveaux derives de la cysteine
BE852457A (fr) Nouveaux derives 17-spirosultines
BE866933A (fr) Nouveaux derives de fortmicine
FR2342963A1 (fr) Derives de la piperidine
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
BE855851A (fr) Nouveaux derives de la nitroxoline
BE851503A (fr) Nouveaux derives de la 2-phenyl-2-hydroxyethylamine

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: KNOLL A.G.

Effective date: 19870131